BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23868972)

  • 1. PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA.
    Struckhoff AP; Rana MK; Kher SS; Burow ME; Hagan JL; Del Valle L; Worthylake RA
    J Cell Sci; 2013 Oct; 126(Pt 19):4514-26. PubMed ID: 23868972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gα
    Castillo-Kauil A; García-Jiménez I; Cervantes-Villagrana RD; Adame-García SR; Beltrán-Navarro YM; Gutkind JS; Reyes-Cruz G; Vázquez-Prado J
    J Biol Chem; 2020 Dec; 295(50):16920-16928. PubMed ID: 33023908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gα13/PDZ-RhoGEF/RhoA signaling is essential for gastrin-releasing peptide receptor-mediated colon cancer cell migration.
    Patel M; Kawano T; Suzuki N; Hamakubo T; Karginov AV; Kozasa T
    Mol Pharmacol; 2014 Sep; 86(3):252-62. PubMed ID: 24958816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic insights into specificity, activity, and regulatory elements of the regulator of G-protein signaling (RGS)-containing Rho-specific guanine nucleotide exchange factors (GEFs) p115, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG).
    Jaiswal M; Gremer L; Dvorsky R; Haeusler LC; Cirstea IC; Uhlenbrock K; Ahmadian MR
    J Biol Chem; 2011 May; 286(20):18202-12. PubMed ID: 21454492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
    Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
    Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
    Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
    Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detrimental Role of PDZ-RhoGEF in Pathological Cardiac Hypertrophy.
    Huang J; Qu Q; Dai Y; Ren D; Qian J; Ge J
    Hypertension; 2023 Feb; 80(2):403-415. PubMed ID: 36448462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-induced Ca2+ sensitization in smooth muscle: redundancy of Rho guanine nucleotide exchange factors (RhoGEFs) and response kinetics, a caged compound study.
    Artamonov MV; Momotani K; Stevenson A; Trentham DR; Derewenda U; Derewenda ZS; Read PW; Gutkind JS; Somlyo AV
    J Biol Chem; 2013 Nov; 288(47):34030-34040. PubMed ID: 24106280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDZ-RhoGEF and LARG are essential for embryonic development and provide a link between thrombin and LPA receptors and Rho activation.
    Mikelis CM; Palmby TR; Simaan M; Li W; Szabo R; Lyons R; Martin D; Yagi H; Fukuhara S; Chikumi H; Galisteo R; Mukouyama YS; Bugge TH; Gutkind JS
    J Biol Chem; 2013 Apr; 288(17):12232-43. PubMed ID: 23467409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation.
    Medlin MD; Staus DP; Dubash AD; Taylor JM; Mack CP
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1779-86. PubMed ID: 20702813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDZ-RhoGEF Is a Signaling Effector for TROY-Induced Glioblastoma Cell Invasion and Survival.
    Ding Z; Dhruv H; Kwiatkowska-Piwowarczyk A; Ruggieri R; Kloss J; Symons M; Pirrotte P; Eschbacher JM; Tran NL; Loftus JC
    Neoplasia; 2018 Oct; 20(10):1045-1058. PubMed ID: 30219706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia-associated Rho guanine nucleotide exchange factor promotes G alpha q-coupled activation of RhoA.
    Booden MA; Siderovski DP; Der CJ
    Mol Cell Biol; 2002 Jun; 22(12):4053-61. PubMed ID: 12024019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time NMR study of guanine nucleotide exchange and activation of RhoA by PDZ-RhoGEF.
    Gasmi-Seabrook GM; Marshall CB; Cheung M; Kim B; Wang F; Jang YJ; Mak TW; Stambolic V; Ikura M
    J Biol Chem; 2010 Feb; 285(8):5137-45. PubMed ID: 20018869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated RhoA binds to the pleckstrin homology (PH) domain of PDZ-RhoGEF, a potential site for autoregulation.
    Chen Z; Medina F; Liu MY; Thomas C; Sprang SR; Sternweis PC
    J Biol Chem; 2010 Jul; 285(27):21070-81. PubMed ID: 20430886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of PDZ-RhoGEF to ATP-binding cassette transporter A1 (ABCA1) induces cholesterol efflux through RhoA activation and prevention of transporter degradation.
    Okuhira K; Fitzgerald ML; Tamehiro N; Ohoka N; Suzuki K; Sawada J; Naito M; Nishimaki-Mogami T
    J Biol Chem; 2010 May; 285(21):16369-77. PubMed ID: 20348106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated localization is sufficient for hormonal control of regulator of G protein signaling homology Rho guanine nucleotide exchange factors (RH-RhoGEFs).
    Carter AM; Gutowski S; Sternweis PC
    J Biol Chem; 2014 Jul; 289(28):19737-46. PubMed ID: 24855647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel role for p21-activated kinase 2 in thrombin-induced monocyte migration.
    Gadepalli R; Kotla S; Heckle MR; Verma SK; Singh NK; Rao GN
    J Biol Chem; 2013 Oct; 288(43):30815-31. PubMed ID: 24025335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of the obscurin-RhoGEF downregulates RhoA signaling and increases microtentacle formation and attachment of breast epithelial cells.
    Perry NA; Vitolo MI; Martin SS; Kontrogianni-Konstantopoulos A
    Oncotarget; 2014 Sep; 5(18):8558-68. PubMed ID: 25261370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mDia2 and CXCL12/CXCR4 chemokine signaling intersect to drive tumor cell amoeboid morphological transitions.
    Wyse MM; Goicoechea S; Garcia-Mata R; Nestor-Kalinoski AL; Eisenmann KM
    Biochem Biophys Res Commun; 2017 Mar; 484(2):255-261. PubMed ID: 28115158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase.
    Zheng R; Iwase A; Shen R; Goodman OB; Sugimoto N; Takuwa Y; Lerner DJ; Nanus DM
    Oncogene; 2006 Sep; 25(44):5942-52. PubMed ID: 16652149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.